Ivonne Haffner

Regulation of arginase‐1 expression in macrophages by a protein kinase a type I and histone deacetylase dependent pathway

L. Holdt, D. Teupser, J. Thiery, 2008, Journal of cellular biochemistry.

Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines

J. Hasenauer, D. Maier, S. Keller, 2018, Molecular oncology.

HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study

J. Hasenauer, A. Walch, F. Lordick, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies—the role of HAS2, SHB and HBEGF

J. Hasenauer, A. Walch, R. Geffers, 2022, BMC Cancer.

Spatial metabolomics identifies distinct tumor-specific subtypes in gastric cancer patients.

R. Langer, A. Feuchtinger, A. Walch, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study

F. Lordick, D. Maier, B. Luber, 2022, Journal of Cancer Research and Clinical Oncology.

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)

M. Zamparini, G. Stocker, G. Baiocchi, 2023, Frontiers in oncology.

Identification of Macrophage Arginase I as a New Candidate Gene of Atherosclerosis Resistance

D. Teupser, J. Thiery, R. Burkhardt, 2005 .

Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer

A. Feuchtinger, A. Walch, F. Lordick, 2024, British journal of cancer.